All Articles
By Jane Morgan
Several immune checkpoint inhibitors are now approved for patients with non-small-cell lung cancer, giving hope to patients living with this disease. Read More ›
“CAR T-cell therapy provides an exciting and additional option for patients who have failed more traditional regimens,” says Dr. Gwen Nichols, Chief Medical Officer for Leukemia & Lymphoma Society. Read More ›
By Wayne Kuznar
The National Comprehensive Cancer Care Network and the American Society of Clinical Oncology recently issued the first set of recommendations for the management of immunotherapy side-effects. Read More ›
By Alisa Lehman
Alisa Lehman’s art depicts cancer as a monster holding her captive in a cage. She recently joined an immunotherapy clinical trial after her medication for metastatic breast cancer stopped working. Read More ›
Cancer treatment costs, and the desire for normalcy and self-worth, are some of the reasons why patients with cancer wish to remain in the workforce. Read More ›
Celebrate milestone events and keep long-term goals. Don’t give them up to cancer! Read More ›
Learn about your legal rights regarding your health insurance or employment, including your right for a family leave related to cancer treatment, job security, and more. Read More ›
The Institute of Medicine suggested that quality of cancer care improves when people who have been diagnosed with cancer share decisions related to their treatment. Read More ›
Hildy Grossman describes her struggle with the stigma linked to a lung cancer diagnosis and her work, through Upstage Lung Cancer and music, to educate the public about lung cancer. Read More ›
New therapies that are now available for people with this type of cancer have fewer side effects than traditional chemotherapy and can improve survival and quality of life. Read More ›